Introduction
Arterial catheters are commonly used in intensive care practice for continuous blood pressure monitoring and blood sampling. The catheter is usually attached to a combined transducer and pressurised flushing system running at a controlled, low, flow rate in order to maintain catheter patency and reduce the incidence of thrombosis. Historically, many intensive care units (ICUs) have used heparin-containing flush solutions to attempt to minimise the incidence of catheter occlusion. Catheter occlusion can lead to patient harm by causing ischaemia distal to the blockage, inaccurate blood pressure measurement, inability to obtain blood samples and patient discomfort due to repeated attempts at re-siting arterial catheters.
The UK National Patient Safety Agency (NPSA) released guidance in 2008 1,2 highlighting potential dangers associated with heparin flushes, including those used with arterial lines, drawing particular attention to the risks of selecting an incorrect flush solution. Two fatalities were reported relating to arterial lines. In one case, inadvertent selection of a glucosecontaining flush solution led to excessive insulin administration due to falsely high blood glucose readings from the arterial blood samples. 3 A further case involved insulin inadvertently used to flush an occluded arterial line. 4 In addition to the two deaths, the NPSA received reports of 82 other incidents up to June 2008 of an incorrect solution being connected to the arterial line. Look-alike labelling and packaging was identified as a contributing factor. Solutions which have been reported as being incorrectly connected include antibiotics, glucose, potassium chloride, mannitol and X-ray contrast media. 2 This led the NPSA to advise that only 0.9% saline without any additional heparin should be used as a flush solution for arterial catheters. This represented a change in practice for many UK ICUs. Following implementation of the guidance in some units in our region, there were anecdotal reports of an increased rate of catheter thrombosis. Our aim was to survey current practice and to observe associated catheter occlusion rates in the member ICUs of the North Western Learning and Development Group (kNOWLEDGe) of the Association of North-Western Intensive Care Units (ANWICU) in England.
Methods
A prospective survey was performed over the period of one calendar month, during March 2012, at eight ANWICU kNOWLEDGe members (four teaching hospitals and four district general hospitals). The study was considered to be a service evaluation, and ethics committee approval was not required nor sought. Each ICU admitted unselected level 2 and 3 patients during the period, including elective and emergency admissions from medical and surgical backgrounds. The
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Original articles catheters were inserted by clinicians in operating theatres, ICUs and emergency departments, using standard local procedures. No attempt was made to standardise practice or equipment. Each ICU followed their normal practice for arterial line maintenance, sampling and removal. Local collaborators at each site arranged for a data collection form to be completed on insertion and removal of arterial catheters. Information was collected regarding the flush solution and system used, type and site of catheter, number of hours the catheter remained in situ, and the reason for removal. Data were pooled and analysed using SPSS 19.0 (IBM systems).
Results
Complete data were collected for 445 catheter insertions from the eight hospitals. Five of the hospitals exclusively used saline as the flush solution for their arterial lines, two exclusively used heparinised saline. One hospital used both types of flush during the study period. All heparinised saline had a concentration of heparin of 1 international unit/mL. The lifespan of any catheter was defined as the time from insertion to the time of removal, and measured to the nearest hour. The main reasons for removal were blockage or that the catheter was no longer required clinically. Overall, 133 catheters (29.9%) were removed due to blockage, with 257 (57.8%) removed as they were no longer required, including 13 patients who died. The remainder were removed either accidentally (16; 3.6%), due to suspected or proven infection (21; 4.7%), with the remaining 17 catheters (4%) removed due to a combination of local haemorrhage, distal vascular insufficiency or elective changes (eg, to facilitate insertion of a specialised cardiac output monitoring catheter). Catheters with heparinised flush solutions (n=151 catheters, 34% of total) had a significantly increased median lifespan of 102 hours versus 72 hours for saline-only flushed catheters (n=294 catheters, 64%, p<0.01 Mann Whitney U test).
Line blockage was prospectively defined as the decision to remove the catheter due to either the inability to aspirate, an unreliable waveform, or distal vascular insufficiency. There was a significant decrease in the likelihood of line blockage in the heparinised flush solution group (blocked n=12, 7.9%) compared with the saline group (n=121, 41.2%, Fishers exact 2-tailed test p<0.0001). Using multiple logistic regression analysis, the odds ratio for the likelihood of blockage when using saline was 19.9 (6.62-59.8). Figure 1 demonstrates the difference in catheter survival between the two groups. As expected, the hospital (ICU) was also a significant factor (likely related to nature of flush solution used at that hospital). No difference was detected between the two different manufacturing brands of arterial catheter used during the study period.
Discussion
Our study has demonstrated that routine heparinisation of arterial flush solutions is associated with a significant decrease in the incidence of arterial catheter occlusion and thrombosis. Furthermore, catheter lifespan also appeared to be associated with flush solution, with median lifespan increasing significantly when using heparinised solutions. Current UK national guidance states, "heparin flushes should not normally be used to flush peripheral intravenous catheters" and that this represents best practice. 2 Our results do not support this position.
Potential problems can occur when using arterial catheter flush solutions. Some of these relate to the additive (wrong concentrations, heparin-induced thrombocytopenia (HIT), theoretically increased bleeding tendency) while some are generic, such as selecting the wrong flush solution (eg a glucose-based solution, with its associated risks of misinterpretation of glycaemic control). Heparin is commercially available in different concentrations and the selection of the incorrect concentrations of heparin solution leading to patient harm has been reported previously. 5 Blockage of arterial lines can also cause increased morbidity and potentially mortality, with problems ranging from inaccurate measurements of invasive blood pressure from a partially occluded catheter, periods without accurate blood pressure monitoring while a blocked line is changed, and distal ischaemia. For the patient, repeated re-insertion of catheters is at best unpleasant and may increase the risks of damage to vessels and adjacent structures.
The existing literature is summarised in Table 1 . The largest study was performed by the American Association of Critical-Care Nurses. 6 This supported the concept that heparin decreased catheter thrombosis, however the pragmatic study design did not allow blinding of the flush solutions. The procedures regarding the management of arterial lines were also not standardised. Other, smaller, studies showed conflicting results. [7] [8] [9] Our observational study had a number of limitations. We did not control for potential differences between patients, locations, equipment, flush sets or practices regarding maintenance and removal of lines between institutions. It is therefore possible that factors other than the flush solution influenced our results. In particular, it is possible that different institutions may have had different thresholds for removal of 
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arterial lines functioning sub-optimally. However, the magnitude of the differences found between the two groups observed in this study, especially the difference in the likelihood of having to remove a line due to blockage, is suggestive that the effect is genuine despite the potential confounding influences.
In conclusion, our results suggest that routine use of heparinised flush solutions for arterial lines in unselected intensive care patients is associated with reduced arterial catheter thrombosis and increased catheter lifespan. There is justification for an adequately powered blinded, randomised controlled trial to test the hypothesis that heparin-containing flush solutions are efficacious in reducing arterial catheter thrombosis. This is an important question, of relevance to the majority of patients in whom invasive monitoring is used in our operating theatres and intensive care units, and may be relevant for other invasive catheters such as those inserted into central veins. Current guidance may need to be reviewed. The NPSA guidance has not eliminated the use of incorrect flush solutions, as demonstrated by a further recent case report of fatal neuroglycopaenia in a UK ICU. 10 A survey of all UK ICUs 11 revealed that 30% of respondents were aware of an incident involving the use of an incorrect arterial catheter flush solution locally. Clearly, other methods of eliminating the use of incorrect flush solutions should be explored, as it is possible that the strategy adopted by the NPSA may have led to the unintended consequence of patient harm resulting from an increase in the incidence of catheter thrombosis, since now only 4.6% of UK ICUs use heparinised flush solutions. 11 Presented in part to the Anaesthetic Research Society, December 2012.
